Calcium and Vitamin D Supplementation in Glucocorticoid Therapy

Introduction to Glucocorticoid-Induced Osteoporosis

• The American College of Rheumatology recommends calcium (1,000-1,200 mg/day) and vitamin D (600-800 IU/day) supplementation for patients with systemic lupus erythematosus on long-term glucocorticoids to prevent osteoporosis and reduce fracture risk 1, 2, 3

Mechanism of Glucocorticoid-Induced Bone Loss

• Glucocorticoids cause bone loss by impairing calcium absorption and increasing renal calcium loss, which can be counteracted by calcium and vitamin D supplementation 4, 5
• The highest rate of bone loss occurs within the first 3-6 months of glucocorticoid treatment, making early supplementation critical 6
• More than 10% of patients on long-term glucocorticoids develop fractures, with 30-40% showing radiographic vertebral fractures 6

Evidence-Based Supplementation Targets

• The American College of Rheumatology provides specific dosing recommendations: 1,000-1,200 mg/day total elemental calcium and 600-800 IU/day minimum vitamin D, with higher doses often required to maintain serum 25(OH)D levels ≥30-50 ng/mL 3
• Vitamin D levels should be monitored and supplementation adjusted accordingly 3

Universal Recommendation Across Risk Levels

• Calcium and vitamin D supplementation is recommended for all patients on long-term glucocorticoids, regardless of fracture risk stratification, as it forms the foundation for all osteoporosis prevention strategies 1, 2, 3
• For moderate to high fracture risk patients, calcium and vitamin D are mandatory adjuncts to bisphosphonates or other anti-fracture medications 1, 2, 3

Clinical Implementation Algorithm

• The European League Against Rheumatism recommends assessing all systemic lupus erythematosus patients for adequate calcium and vitamin D intake, with supplementation guided by osteoporosis screening protocols for those on steroids 7, 8
• For all patients starting or continuing prednisone ≥2.5 mg/day for ≥3 months, initiate calcium and vitamin D supplementation immediately, without waiting for bone density testing 1, 2, 3

Evidence Quality and Rationale

• The recommendation for calcium and vitamin D supplementation is conditional due to low-quality direct evidence, but is based on indirect evidence, biological plausibility, and proven efficacy in reducing glucocorticoid-induced bone loss when combined with bisphosphonates 1, 2, 4, 5

Calcium, Vitamin D, and Bisphosphonate Recommendations for Steroid‑Treated Sarcoidosis Patients

Guideline Recommendations for Calcium and Vitamin D Supplementation

• The American College of Rheumatology (ACR) recommends that all patients receiving long‑term glucocorticoids (≥ 3 months at ≥ 2.5 mg/day prednisone) take calcium 1,000–1,200 mg daily and vitamin D 600–800 IU daily. 9
• The ACR also advises the same calcium and vitamin D dosing for patients on long‑term glucocorticoids (≥ 3 months at ≥ 2.5 mg/day prednisone). 10
• The European League Against Rheumatism (EULAR) recommends calcium and vitamin D supplementation for patients on prednisone > 7.5 mg/day for more than 3 months. 11

Baseline Assessment Prior to Supplementation

• According to the ACR, clinicians should document the current glucocorticoid dose and the anticipated duration of therapy before deciding on calcium or vitamin D supplementation. 9

Management When Calcium/Vitamin D Cannot Be Used

• The ACR advises that patients with moderate‑to‑high fracture risk who cannot tolerate calcium or vitamin D should receive oral bisphosphonate therapy (alendronate or risedronate preferred) without calcium supplementation. [9][10]
• The ACR further states that if fracture risk is moderate‑to‑high based on ACR criteria (history of osteoporotic fracture, FRAX 10‑year major osteoporotic fracture risk ≥ 10 %, or hip fracture risk > 1 %), bisphosphonate therapy should be initiated directly, without first attempting calcium or vitamin D optimization. [9][10]

Lifestyle and Non‑Pharmacologic Recommendations

• The ACR recommends lifestyle measures for bone health, including regular weight‑bearing exercise, smoking cessation, and limiting alcohol intake to 1–2 drinks per day. 10